Russell N Van Gelder, MD
Synopsis: Several options are available to the clinician for treating non-infectious uveitis. Corti- costeroid implants including the ﬂuocinolone acetonide sustained release devices have been extensively tested in uveitic patients and shown to be efﬁcacious. Similarly, a number of immu- nomodulatory therapies have been shown to be beneﬁcial for chronic uveitis. The Multi-centre Uveitis Steroid Trial (MUST) has examined the relative merits of these two approaches. In this talk, the relative efﬁcacy and side effects of these approaches will be discussed as well as the implications for sequencing treatment of disease.